Eli Lilly and Receives Neutral Rating from Zacks

Home › Eli Lilly and Receives Neutral Rating from Zacks

's stock had its "neutral" rating restated by Zacks in a report released on Friday.

01.11	Eastern North Pacific Tropical Weather Outlook
01.11	Atlantic Tropical Weather Outlook
01.11	CERM launches new MIS products, Mark Andy innovates and more
01.11	Removing a major trade barrier: Full access to Colombia restored for U.S. beef
01.11	Getting more out of fall and winter grazing
01.11	U.S. Boston butt burger launches in Colombia
01.11	All Americans have a role in keeping African swine fever out
01.11	BASF TotalEnergies Petrochemicals Receives United Way Champions of Hope Award
More »

je.st